发明名称 |
Treatment of multiple sclerosis with combination of laquinimod and interferon-beta |
摘要 |
This disclosure provides a method of treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the patient laquinimod as an add-on therapy to or in combination with interferon-&bgr;. This invention also provides a package and a pharmaceutical composition comprising laquinimod and interferon-&bgr; for treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This disclosure also provides laquinimod for use as an add-on therapy or in combination with interferon-&bgr; in treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This disclosure further provides use of laquinimod and interferon-&bgr; in the preparation of a combination for treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome. |
申请公布号 |
NZ621215(A) |
申请公布日期 |
2015.11.27 |
申请号 |
NZ20120621215 |
申请日期 |
2012.07.27 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
TARCIC NORA;GILGUN YOSSI |
分类号 |
A61K31/4704;A61K38/21;A61P25/00;A61P37/02 |
主分类号 |
A61K31/4704 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|